Jiqiang Lin is an Associate at Cooley LLP, specializing in Life Sciences Corporate Partnering and Licensing since November 2021. Previous experience includes serving as an Associate at Latham & Watkins from October 2018 to November 2021, focusing on Life Sciences Technology Transactions, and as a Summer Associate at the same firm in May 2017. Additionally, Jiqiang Lin was a Regulatory Intern at Pfizer in 2016, where analysis of regulatory trends for the vaccine Prevnar and the development of regulatory strategies for emerging markets took place. Jiqiang Lin holds a Juris Doctor (J.D.) from New York University School of Law, a Doctor of Philosophy (Ph.D.) in Molecular Oncology and Immunology from the NYU School of Medicine, and a Bachelor's Degree in Biology from Peking University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices